4.6 Article

PLASMA BACTERIAL AND MITOCHONDRIAL DNA DISTINGUISH BACTERIAL SEPSIS FROM STERILE SYSTEMIC INFLAMMATORY RESPONSE SYNDROME AND QUANTIFY INFLAMMATORY TISSUE INJURY IN NONHUMAN PRIMATES

Journal

SHOCK
Volume 39, Issue 1, Pages 55-62

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/SHK.0b013e318276f4ca

Keywords

Sepsis; inflammation; bacteremia; systemic inflammatory response syndrome; trauma

Funding

  1. National Institutes of Health/National Institute of General Medical Sciences [R01 GM089711]
  2. Department of Defense CDMRP/DRMRP hypothesis development award [DR080924]
  3. National Institutes of Health/National Institute of Allergy and Infectious Diseases [RO1 AI058107, UO1 AI1075386, U19 AI062629]
  4. NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI062629, R01AI058107, U01AI075386] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089711] Funding Source: NIH RePORTER

Ask authors/readers for more resources

Systemic inflammatory response syndrome (SIRS) is a fundamental host response common to bacterial infection and sterile tissue injury. Systemic inflammatory response syndrome can cause organ dysfunction and death, but its mechanisms are incompletely understood. Moreover, SIRS can progress to organ failure or death despite being sterile or after control of the inciting infection. Biomarkers discriminating between sepsis, sterile SIRS, and postinfective SIRS would therefore help direct care. Circulating mitochondrial DNA (mtDNA) is a damage-associated molecular pattern reflecting cellular injury. Circulating bacterial 16S DNA (bDNA) is a pathogen-associated pattern (PAMP) reflecting ongoing infection. We developed quantitative polymerase chain reaction assays to quantify these markers, and predicting their plasma levels might help distinguish sterile injury from infection. To study these events in primates, we assayed banked serum from Papio baboons that had undergone a brief challenge of intravenous Bacillus anthracis delta Sterne (modified to remove toxins) followed by antibiotics (anthrax) that causes organ failure and death. To investigate the progression of sepsis to severe sepsis and death, we studied animals where anthrax was pretreated with drotrecogin alfa (activated protein C), which attenuates sepsis in baboons. We also contrasted lethal anthrax bacteremia against nonlethal E. coli bacteremia and against sterile tissue injury from Shiga-like toxin 1. Bacterial DNA and mtDNA levels in timed samples were correlated with blood culture results and assays of organ function. Sterile injury by Shiga-like toxin 1 increased mtDNA, but bDNA was undetectable: consistent with the absence of infection. The bacterial challenges caused parallel early bDNA and mtDNA increases, but bDNA detected pathogens even after bacteria were undetectable by culture. Sublethal E. coli challenge only caused transient rises in mtDNA consistent with a self-limited injury. In lethal anthrax challenge (n = 4), bDNA increased transiently, but mtDNA levels remained elevated until death, consistent with persistent septic tissue damage after bacterial clearance. Critically, activated protein C pretreatment (n = 4) allowed mtDNA levels to decay after bacterial clearance with sparing of organ function and survival. In summary, host tissue injury correlates with mtDNA whether infective or sterile. Mitochondria' DNA and bDNA polyrnerase chain reactions can quantify tissue injury incurred by septic or sterile mechanisms and suggest the source of SIRS of unknown origin.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available